An open label single arm clinical study of ushiradi vati in emesis gravidarum(garbhini chardi)
Not Applicable
- Conditions
- Health Condition 1: O99- Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2021/11/038162
- Lead Sponsor
- Anurag Kisan Jadhav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All diagnosed Garbhini chardi patients with GA 6th week to 14th weeks having single live intrauterine pregnancy irrespective of parity & religion .
2.All diagnosed Garbhini chardi patients having age group 19-35 years.
Exclusion Criteria
1. patient with multiple pregnancy and vesicular mole.
2. garbhini with complaints of Krumij chardi and Ajirnaj chardi .
3.pregnant women with vomitting due to other systemic diseases peptic ulcer, liver & kidney diseases, hypertension etc.
4.k/c/o diabetes mellitus / gestational diabetes mellitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method primary outcome- <br/ ><br>1.To study the effect of Ushiradi vati in Garbhini Chardi(emesis gravidarum)Timepoint: for each patient treatment duration 56 days <br/ ><br>clinical study within 14 months(all 45 patient)
- Secondary Outcome Measures
Name Time Method 1.Garbhini chardi will be studied in detail <br/ ><br>2.to study etiopathogenesis of garbhini chardi . <br/ ><br>3.adverse effects of Ushiradi vati if any will be observed during study .Timepoint: 14 months